BioSpace News Archive

Business

Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

Agilent Technologies Inc. (NYSE: A) today announced an agreement with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services.

January 23, 2023
·
7 min read
Business

Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy

Gemina Laboratories Ltd. is delighted to announce that it has appointed Dr. Stefan Hamill as Vice President, Strategy of the Company.

January 23, 2023
·
5 min read
Business

Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million

Clinigen Limited (‘Clinigen’) (‘the Company’), the global pharmaceutical services company, has entered into an agreement to divest Proleukin® (interleukin-2 (aldesleukin)), to Iovance Biotherapeutics, Inc.

January 23, 2023
·
9 min read
The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital selects Cubresa’s BrainPET Insert System to support brain research studies

The Martinos Center has selected Cubresa’s investigational BrainPET System to add to their suite of imaging tools.

January 23, 2023
·
2 min read
ALERCELL Announces the Launch of LENA Q51®

ALERCELL, INC. announced today that it has introduced a new Research Use Only (RUO) LENA Q51® Leukemia diagnostic test for commercial sale.

January 23, 2023
·
3 min read
Business

Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the board of directors has been established for Magdalena Biosciences, Inc., the joint venture recently formed by Jaguar and Filament Health Corp.

January 23, 2023
·
8 min read
Genetown

NeuroMetrix® Announces Launch of DPNCheck® 2.0, its Fast, Accurate, Quantitative Screening Test for Peripheral Neuropathy

NeuroMetrix, Inc. announced the commercial availability of DPNCheck 2.0, the Company’s latest point-of-care device that leverages gold-standard nerve conduction technology to detect peripheral neuropathy.

January 23, 2023
·
2 min read
Drug Development

AltruBio Announces First Patient Dosed in Phase 1 Trial of Next-Generation Immune Checkpoint Enhancer ALTB-268 for the Treatment of Ulcerative Colitis

AltruBio Inc. (“AltruBio” or “the Company”) today announced that it has dosed the first patient in a Phase 1 study evaluating ALTB-268, its next-generation PSGL-1 antibody agonist serving as an immune checkpoint enhancer (ICE), in healthy volunteers.

January 23, 2023
·
3 min read
Business

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023.

January 23, 2023
·
5 min read
Business

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

BillionToOne, Inc., a next-generation molecular diagnostics company, is excited to announce the appointment of Dr. Gary Palmer as Chief Medical Officer, Oncology, and the launch of its Northstar liquid biopsy assays for commercial use.

January 23, 2023
·
3 min read